We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
Cap. Flow
+$560M
Cap. Flow %
3.31%
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$57.5M
2
EMR icon
Emerson Electric
EMR
+$45M
3
JNJ icon
Johnson & Johnson
JNJ
+$41.1M
4
WEC icon
WEC Energy
WEC
+$36.5M
5
CLX icon
Clorox
CLX
+$31.8M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$63.8M
2
CVX icon
Chevron
CVX
+$33.9M
3
SLB icon
SLB Ltd
SLB
+$32.7M
4
LRCX icon
Lam Research
LRCX
+$22.8M
5
MRK icon
Merck
MRK
+$21.9M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Healthcare 16.61%
3 Financials 14.79%
4 Communication Services 9.7%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMS
1051
DELISTED
Adamas Pharmaceuticals
ADMS
$216K ﹤0.01%
9,400
-200
-2% -$4.7K
TWLO icon
1052
Twilio
TWLO
$38B
$214K ﹤0.01%
2,672
+1,622
+154% +$119K
PACB icon
1053
Pacific Biosciences
PACB
$357M
$213K ﹤0.01%
46,000
-1,000
-2% -$4.29K
ACHN
1054
DELISTED
Achillion Pharmaceuticals
ACHN
$211K ﹤0.01%
66,300
-2,000
-3% -$5.96K
VNDA icon
1055
Vanda Pharmaceuticals
VNDA
$304M
$209K ﹤0.01%
10,600
-300
-3% -$6.13K
SFUN
1056
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$209K ﹤0.01%
148
– –
SPPI
1057
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$208K ﹤0.01%
9,200
-60,200
-87% -$1.3M
PGNX
1058
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$208K ﹤0.01%
26,500
-500
-2% -$3.84K
RIGL icon
1059
Rigel Pharmaceuticals
RIGL
$778M
$207K ﹤0.01%
6,250
– –
JE
1060
DELISTED
Just Energy Group Inc
JE
$207K ﹤0.01%
2,088
– –
AGM icon
1061
Federal Agricultural Mortgage
AGM
$2.54B
$206K ﹤0.01%
2,654
– –
OTEX icon
1062
Open Text
OTEX
$5.99B
$205K ﹤0.01%
5,177
– –
CBIO
1063
Crescent Biopharma
CBIO
$644M
$200K ﹤0.01%
134
-3
-2% -$4.54K
EGBN icon
1064
Eagle Bancorp
EGBN
$843M
$198K ﹤0.01%
3,692
+1,492
+68% +$82.8K
ASRT
1065
DELISTED
Assertio
ASRT
$194K ﹤0.01%
495
-17
-3% -$7.42K
OIS icon
1066
Oil States International
OIS
$534M
$192K ﹤0.01%
5,615
– –
SGYP
1067
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$192K ﹤0.01%
99,000
– –
PBR icon
1068
Petrobras
PBR
$118B
$189K ﹤0.01%
18,000
– –
ERF
1069
DELISTED
Enerplus Corporation
ERF
$188K ﹤0.01%
15,000
+2,700
+22% +$33.9K
ACRS icon
1070
Aclaris Therapeutics
ACRS
$867M
$187K ﹤0.01%
12,700
– –
NVAX icon
1071
Novavax
NVAX
$1.3B
$185K ﹤0.01%
6,155
– –
INO icon
1072
Inovio Pharmaceuticals
INO
$76.1M
$184K ﹤0.01%
3,033
-84
-3% -$4.68K
SIGI icon
1073
Selective Insurance
SIGI
$5.66B
$184K ﹤0.01%
2,900
– –
BERY
1074
DELISTED
Berry Global Group, Inc.
BERY
$181K ﹤0.01%
4,134
– –
CCJ icon
1075
Cameco
CCJ
$42.4B
$174K ﹤0.01%
16,863
– –
41 42
43
44 45

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review

As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
  • DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
  • DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
  • DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
  • DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
  • DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.